Richard Brudnick

Independent Director

Richard Brudnick Photo 12 18

Mr. Brudnick has held senior positions in the areas of Portfolio Strategy & Business Development and Corporate Development in a number of pharmaceutical companies and currently serves as Chief Business Officer and Head of Corporate Strategy of Codiak BioSciences, Inc., (NASDAQ GS: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a position he has held since June 2018.

Mr. Brudnick received a B.S. and M.S. in Management Science from the Massachusetts Institute of Technology.